UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 538

Sortiert nach

Toxic epidermal necrolysis and Stevens-Johnson syndrome

Orphanet journal of rare diseases, 2010-12, Vol.5 (1), p.39-39, Article 39

2010

Volltextzugriff (PDF)

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

Journal of the American Academy of Dermatology, 2021-07, Vol.85 (1), p.46-55

2021

Volltextzugriff (PDF)

The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries

Journal of the American Academy of Dermatology, 2020-10, Vol.83 (4), p.1118-1129

2020

Volltextzugriff (PDF)

The Crosstalk between Nrf2 and Inflammasomes

International journal of molecular sciences, 2018-02, Vol.19 (2), p.562

2018

Volltextzugriff (PDF)

Cytotoxic Cutaneous Adverse Drug Reactions during Anti-PD-1 Therapy

Clinical cancer research, 2016-08, Vol.22 (16), p.4023-4029

2016

Volltextzugriff (PDF)

TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis

Nature communications, 2018-01, Vol.9 (1), p.25-25, Article 25

2018

Volltextzugriff (PDF)

Long COVID in the skin: a registry analysis of COVID-19 dermatological duration

The Lancet infectious diseases, 2021-03, Vol.21 (3), p.313-314

2021

Volltextzugriff (PDF)

Genome Editing of Human Primary Keratinocytes by CRISPR/Cas9 Reveals an Essential Role of the NLRP1 Inflammasome in UVB Sensing

Journal of investigative dermatology, 2018-12, Vol.138 (12), p.2644-2652

2018

Volltextzugriff (PDF)

Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study

Journal of the American Academy of Dermatology, 2022-01, Vol.86 (1), p.113-121

2022

Volltextzugriff (PDF)

Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases

Frontiers in pharmacology, 2017-05, Vol.8, p.278-278

2017

Volltextzugriff (PDF)

Therapeutic potential of targeting interleukin‐1 family cytokines in chronic inflammatory skin diseases

British journal of dermatology (1951), 2022-06, Vol.186 (6), p.925-941

2022

Volltextzugriff (PDF)

Propionibacterium acnes Promotes Th17 and Th17/Th1 Responses in Acne Patients

Journal of investigative dermatology, 2015-01, Vol.135 (1), p.110-118

2015

Volltextzugriff (PDF)

Inflammation: A Contributor to Depressive Comorbidity in Inflammatory Skin Disease

Skin pharmacology and physiology, 2018-01, Vol.31 (5), p.246-251

2018

Volltextzugriff (PDF)

Caspase-4 is required for activation of inflammasomes

The Journal of immunology (1950), 2012-02, Vol.188 (4), p.1992-2000

2012

Volltextzugriff (PDF)

RASopathic skin eruptions during vemurafenib therapy

PloS one, 2013-03, Vol.8 (3), p.e58721

2013

Volltextzugriff (PDF)

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort

Inflammatory bowel diseases, 2015-08, Vol.21 (8), p.1794-1800

2015

Volltextzugriff (PDF)

In Situ Mapping of Innate Lymphoid Cells in Human Skin: Evidence for Remarkable Differences between Normal and Inflamed Skin

Journal of investigative dermatology, 2016-12, Vol.136 (12), p.2396-2405

2016

Volltextzugriff (PDF)

Quality of Life and Psychopathology in Lichen Planus: A Neglected Disease Burden

Acta dermato-venereologica, 2021-12, Vol.101 (12), p.adv00619-adv00619

2021

Volltextzugriff (PDF)

The Nlrp3 inflammasome regulates acute graft-versus-host disease

The Journal of experimental medicine, 2013-09, Vol.210 (10), p.1899-1910

2013

Volltextzugriff (PDF)

Caspase-1 Activity Is Required for UVB-Induced Apoptosis of Human Keratinocytes

Journal of investigative dermatology, 2015-05, Vol.135 (5), p.1395-1404

2015

Volltextzugriff (PDF)

Dietary Patterns in Acne and Rosacea Patients—A Controlled Study and Comprehensive Analysis

Nutrients, 2023-10, Vol.15 (20), p.4405

2023

Volltextzugriff (PDF)

Opposing effects of Nrf2 and Nrf2‐activating compounds on the NLRP3 inflammasome independent of Nrf2‐mediated gene expression

European journal of immunology, 2017-05, Vol.47 (5), p.806-817

2017

Volltextzugriff (PDF)

Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis

Journal of investigative dermatology, 2019-04, Vol.139 (4), p.848-858

2019

Volltextzugriff (PDF)

Toxic Epidermal Necrolysis and Stevens Johnson Syndrome: Our Current Understanding

Allergology International, 2006, Vol.55 (1), p.9-16

French, Lars E

2006

Volltextzugriff (PDF)

Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors

Cancers, 2023-04, Vol.15 (9), p.2538

2023

Volltextzugriff (PDF)

1 – 25 von 538

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(452)
Mit Volltextzugriff
(455)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Toxic epidermal necrolysis and Stevens-Johnson syndrome

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries

The Crosstalk between Nrf2 and Inflammasomes

Cytotoxic Cutaneous Adverse Drug Reactions during Anti-PD-1 Therapy

TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis

Long COVID in the skin: a registry analysis of COVID-19 dermatological duration

Genome Editing of Human Primary Keratinocytes by CRISPR/Cas9 Reveals an Essential Role of the NLRP1 Inflammasome in UVB Sensing

Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study

Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases

Therapeutic potential of targeting interleukin‐1 family cytokines in chronic inflammatory skin diseases

Propionibacterium acnes Promotes Th17 and Th17/Th1 Responses in Acne Patients

Inflammation: A Contributor to Depressive Comorbidity in Inflammatory Skin Disease

Caspase-4 is required for activation of inflammasomes

RASopathic skin eruptions during vemurafenib therapy

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort

In Situ Mapping of Innate Lymphoid Cells in Human Skin: Evidence for Remarkable Differences between Normal and Inflamed Skin

Quality of Life and Psychopathology in Lichen Planus: A Neglected Disease Burden

The Nlrp3 inflammasome regulates acute graft-versus-host disease

Caspase-1 Activity Is Required for UVB-Induced Apoptosis of Human Keratinocytes

Dietary Patterns in Acne and Rosacea Patients—A Controlled Study and Comprehensive Analysis

Opposing effects of Nrf2 and Nrf2‐activating compounds on the NLRP3 inflammasome independent of Nrf2‐mediated gene expression

Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis

Toxic Epidermal Necrolysis and Stevens Johnson Syndrome: Our Current Understanding

Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors

Suchergebnisse filtern